EUVIMEDEUVIMED entdecken
Crossref

TET2 and LILRB1 mutations are frequent in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma especially in elderly patients

Junhun Cho iD, Eojin Kim, Sang Eun Yoon, Seok Jin Kim iD, Won Seog Kim

Cancer · 2023

DOI: 10.1002/cncr.34698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2023. Verfasst von Junhun Cho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Lymphoma, Large B-Cell, Diffuse, Dioxygenases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse large B‐cell lymphoma (DLBCL) harboring Epstein–Barr virus (EBV) primarily occurs in patients who have underlying immunodeficiency or in elderly patients but is also reported in young, immunocompetent patients. The authors investigated the pathologic differences in EBV‐positive DLBCL in these three groups of patients.

Methods

In total, 57 patients with EBV‐positive DLBCL were included in the study; of these, 16 patients had associated immunodeficiency, 10 were young (younger than 50 years), and 31 were elderly (aged 50 years or older). Immunostaining for CD8, CD68, PD‐L1, and EBV nuclear antigen 2, and panel‐based next‐generation sequencing was performed on formalin‐fixed, paraffin‐embedded blocks.

Results

Immunohistochemistry revealed EBV nuclear antigen 2 positivity in 21 of the 49 patients. The degree of CD8‐positive and CD68‐positive immune cell infiltration and PD‐L1 expression did not differ significantly in each group. Extranodal site involvement was more common in young patients ( p = .021). In mutational analysis, the genes with the highest mutation frequency were PCLO ( n = 14), TET2 ( n = 10), and LILRB1 ( n = 10). For the TET2 gene, all 10 mutations were found in elderly patients ( p = .007). Compared with a validation cohort, both TET2 and LILRB1 showed a higher mutation frequency in EBV‐positive patients than in EBV‐negative patients.

Conclusions

EBV‐positive DLBCL occurring in three different age and immune status groups showed similar pathologic characteristics. Notably, a high frequency of TET2 and LILRB1 mutations was characteristic of this disease in elderly patients. Further studies are needed to determine the role of TET2 and LILRB1 mutations in the development of EBV‐positive DLBCL along with immune senescence. Plain Language Summary Epstein–Barr virus‐positive diffuse large B‐cell lymphoma occurring in three different groups (immunodeficiency‐associated, young, and elderly) showed similar pathologic characteristics. The frequency of TET2 and LILRB1 mutations was high in elderly patients with Epstein–Barr virus‐positive diffuse large B‐cell lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsLymphoma, Large B-Cell, DiffuseDioxygenasesAgedHumansHerpesvirus 4, HumanB7-H1 AntigenLeukocyte Immunoglobulin-like Receptor B1Epstein-Barr Virus Nuclear AntigensMutationAntigens, CDDNA-Binding Proteins

Stichwörter der Autor:innen

Epstein-Barr virusLILRB1TET2diffuse large B-cell lymphomaelderly

Substanzen

B7-H1 AntigenLeukocyte Immunoglobulin-like Receptor B1Epstein-Barr Virus Nuclear AntigensLILRB1 protein, humanAntigens, CDTET2 protein, humanDNA-Binding ProteinsDioxygenases

Autor:innen und Institutionen

  • Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ORCID-Profile: Junhun Cho, Seok Jin Kim

Zitieren

APA

Cho, J., Kim, E., Yoon, S. E., Kim, S. J., & Kim, W. S. (2023). TET2 and LILRB1 mutations are frequent in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma especially in elderly patients. Cancer. https://doi.org/10.1002/cncr.34698

Vancouver

Cho J, Kim E, Yoon SE, Kim SJ, Kim WS. TET2 and LILRB1 mutations are frequent in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma especially in elderly patients. Cancer. 2023. doi:10.1002/cncr.34698

BibTeX
@article{Cho2023,
  author = {Cho, Junhun and Kim, Eojin and Yoon, Sang Eun and Kim, Seok Jin and Kim, Won Seog},
  title = {TET2 and LILRB1 mutations are frequent in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma especially in elderly patients},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.34698}
}
Kostenlos starten →